Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
J Am Acad Dermatol
; 85(5): 1093-1106, 2021 11.
Article
en En
| MEDLINE
| ID: mdl-33945836
Palabras clave
CD30(+) lymphoproliferative disorders; Sézary syndrome; adult T-cell leukemia; adult T-cell lymphoma; angioimmunoblastic T-cell lymphoma; brentuximab; cutaneous T-cell lymphoma; cytotoxic T-cell lymphoma; extranodal NK/T-cell lymphoma; immunomodulators; mycosis fungoides; nasal type; non-MF/SS; not otherwise specified; peripheral T-cell lymphoma; phototherapy; primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder; primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T-cell lymphoma; primary cutaneous acral CD8(+) T-cell lymphoma; primary cutaneous gamma-delta T-cell lymphoma; prognosis; skin-directed treatment; staging; subcutaneous panniculitis-like T-cell lymphoma; systemic treatment; targeted therapies; topical corticosteroids
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Cutáneas
/
Linfoma Cutáneo de Células T
/
Micosis Fungoide
/
Síndrome de Sézary
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
J Am Acad Dermatol
Año:
2021
Tipo del documento:
Article